CN106110384A - 一种基于超临界流体技术的载药气凝胶制备方法 - Google Patents
一种基于超临界流体技术的载药气凝胶制备方法 Download PDFInfo
- Publication number
- CN106110384A CN106110384A CN201610595379.4A CN201610595379A CN106110384A CN 106110384 A CN106110384 A CN 106110384A CN 201610595379 A CN201610595379 A CN 201610595379A CN 106110384 A CN106110384 A CN 106110384A
- Authority
- CN
- China
- Prior art keywords
- still
- medicine
- chitosan
- carbon dioxide
- aeroge
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 205
- 239000012530 fluid Substances 0.000 title claims abstract description 36
- 238000002360 preparation method Methods 0.000 title claims abstract description 25
- 238000005516 engineering process Methods 0.000 title claims abstract description 23
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 168
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 83
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 83
- 229920001661 Chitosan Polymers 0.000 claims abstract description 78
- 238000004090 dissolution Methods 0.000 claims abstract description 61
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000011068 loading method Methods 0.000 claims abstract description 27
- 229940079593 drug Drugs 0.000 claims abstract description 26
- 238000001035 drying Methods 0.000 claims abstract description 13
- 239000000017 hydrogel Substances 0.000 claims abstract description 10
- 230000009471 action Effects 0.000 claims abstract description 9
- AVPCPPOOQICIRJ-UHFFFAOYSA-L sodium glycerol 2-phosphate Chemical compound [Na+].[Na+].OCC(CO)OP([O-])([O-])=O AVPCPPOOQICIRJ-UHFFFAOYSA-L 0.000 claims description 36
- 238000005485 electric heating Methods 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 21
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 19
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 19
- 229910000831 Steel Inorganic materials 0.000 claims description 16
- 239000010959 steel Substances 0.000 claims description 16
- NWXMGUDVXFXRIG-WESIUVDSSA-N (4s,4as,5as,6s,12ar)-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4,4a,5,5a-tetrahydrotetracene-2-carboxamide Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(=O)C(C(N)=O)=C(O)[C@@]4(O)C(=O)C3=C(O)C2=C1O NWXMGUDVXFXRIG-WESIUVDSSA-N 0.000 claims description 13
- 229930195573 Amycin Natural products 0.000 claims description 13
- 229930012538 Paclitaxel Natural products 0.000 claims description 13
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 13
- 229960001592 paclitaxel Drugs 0.000 claims description 13
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 12
- 238000007598 dipping method Methods 0.000 claims description 11
- 229940054190 hydroxypropyl chitosan Drugs 0.000 claims description 11
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 10
- 229920002674 hyaluronan Polymers 0.000 claims description 10
- 229960003160 hyaluronic acid Drugs 0.000 claims description 10
- GAGWJHPBXLXJQN-UORFTKCHSA-N Capecitabine Chemical compound C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1[C@H]1[C@H](O)[C@H](O)[C@@H](C)O1 GAGWJHPBXLXJQN-UORFTKCHSA-N 0.000 claims description 8
- GAGWJHPBXLXJQN-UHFFFAOYSA-N Capecitabine Natural products C1=C(F)C(NC(=O)OCCCCC)=NC(=O)N1C1C(O)C(O)C(C)O1 GAGWJHPBXLXJQN-UHFFFAOYSA-N 0.000 claims description 8
- 229960004117 capecitabine Drugs 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 4
- 241000790917 Dioxys <bee> Species 0.000 claims description 4
- 230000033228 biological regulation Effects 0.000 claims description 4
- 229910052799 carbon Inorganic materials 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 21
- 230000008569 process Effects 0.000 abstract description 17
- 239000000203 mixture Substances 0.000 abstract description 5
- 229960002901 sodium glycerophosphate Drugs 0.000 abstract description 4
- 238000011017 operating method Methods 0.000 abstract description 3
- 230000006641 stabilisation Effects 0.000 abstract description 2
- 238000011105 stabilization Methods 0.000 abstract description 2
- REULQIKBNNDNDX-UHFFFAOYSA-M sodium;2,3-dihydroxypropyl hydrogen phosphate Chemical compound [Na+].OCC(O)COP(O)([O-])=O REULQIKBNNDNDX-UHFFFAOYSA-M 0.000 abstract 3
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229960004424 carbon dioxide Drugs 0.000 description 69
- 238000013461 design Methods 0.000 description 9
- 239000002904 solvent Substances 0.000 description 7
- 239000002131 composite material Substances 0.000 description 5
- 230000006196 deacetylation Effects 0.000 description 5
- 238000003381 deacetylation reaction Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 150000004676 glycans Chemical class 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 239000004964 aerogel Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000009513 drug distribution Methods 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229910000975 Carbon steel Inorganic materials 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- GCNLQHANGFOQKY-UHFFFAOYSA-N [C+4].[O-2].[O-2].[Ti+4] Chemical compound [C+4].[O-2].[O-2].[Ti+4] GCNLQHANGFOQKY-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 229910002090 carbon oxide Inorganic materials 0.000 description 1
- 239000010962 carbon steel Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol Substances OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- -1 hydroxypropyl Chemical group 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 238000005554 pickling Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610595379.4A CN106110384B (zh) | 2016-07-27 | 2016-07-27 | 一种基于超临界流体技术的载药气凝胶制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610595379.4A CN106110384B (zh) | 2016-07-27 | 2016-07-27 | 一种基于超临界流体技术的载药气凝胶制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106110384A true CN106110384A (zh) | 2016-11-16 |
CN106110384B CN106110384B (zh) | 2019-02-01 |
Family
ID=57289940
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610595379.4A Active CN106110384B (zh) | 2016-07-27 | 2016-07-27 | 一种基于超临界流体技术的载药气凝胶制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106110384B (zh) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107855080A (zh) * | 2017-10-30 | 2018-03-30 | 中国科学院过程工程研究所 | 高分子凝胶颗粒、其制备方法、包含其的复合凝胶颗粒及用途 |
CN108421081A (zh) * | 2018-04-03 | 2018-08-21 | 广东海洋大学 | 一种抗感染、安全高效的止血气凝胶及其制备方法 |
CN108905884A (zh) * | 2018-06-01 | 2018-11-30 | 东南大学 | 一种改进的超临界抗溶剂法制备聚合物载药颗粒装置 |
CN108955096A (zh) * | 2018-05-22 | 2018-12-07 | 航天特种材料及工艺技术研究所 | 一种超临界二氧化碳干燥的方法 |
CN109985581A (zh) * | 2018-01-03 | 2019-07-09 | 天津城建大学 | 碳纳米管-蒙脱土复合气凝胶材料及其制备方法 |
CN112220962A (zh) * | 2020-10-30 | 2021-01-15 | 北京福爱乐科技发展有限公司 | 一种快速止血的医用胶材料及其制备方法 |
CN112263707A (zh) * | 2020-10-30 | 2021-01-26 | 北京福爱乐科技发展有限公司 | 一种抗感染医用胶材料及其制备方法 |
CN112295013A (zh) * | 2020-10-30 | 2021-02-02 | 北京福爱乐科技发展有限公司 | 一种消炎型快速止血医用胶材料及其制备方法 |
CN112316201A (zh) * | 2020-10-30 | 2021-02-05 | 北京福爱乐科技发展有限公司 | 一种抗菌型快速止血医用胶材料及其制备方法 |
CN114533965A (zh) * | 2022-02-22 | 2022-05-27 | 大连大学 | 一种聚合物基羟基磷灰石复合材料负载头孢羟氨苄及其制备方法与应用 |
CN115531615A (zh) * | 2022-09-19 | 2022-12-30 | 沈阳百奥医疗器械有限公司 | 一种浸渍载药方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020086070A1 (en) * | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
US20060223965A1 (en) * | 2005-03-31 | 2006-10-05 | Aspen Aerogels Inc. | High strength organic-inorganic hybrid gel materials |
US20130018112A1 (en) * | 2009-09-14 | 2013-01-17 | University Of Nottingham | Cellulose nanoparticle aerogels, hydrogels and organogels |
CN103251974A (zh) * | 2013-05-10 | 2013-08-21 | 浙江大学 | 一种基于超临界流体技术的载药伤口敷料制备方法 |
CN103315980A (zh) * | 2013-06-09 | 2013-09-25 | 浙江大学 | 一种基于超临界流体技术的黏膜附着性聚合物载药贴膜制备方法 |
CN104031386A (zh) * | 2014-05-26 | 2014-09-10 | 中国科学院宁波材料技术与工程研究所 | 一种复合气凝胶及其制备方法 |
CN104958252A (zh) * | 2015-06-24 | 2015-10-07 | 青岛农业大学 | 一种壳聚糖载药温敏水凝胶、制备方法及其应用 |
-
2016
- 2016-07-27 CN CN201610595379.4A patent/CN106110384B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020086070A1 (en) * | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
US20060223965A1 (en) * | 2005-03-31 | 2006-10-05 | Aspen Aerogels Inc. | High strength organic-inorganic hybrid gel materials |
US20130018112A1 (en) * | 2009-09-14 | 2013-01-17 | University Of Nottingham | Cellulose nanoparticle aerogels, hydrogels and organogels |
CN103251974A (zh) * | 2013-05-10 | 2013-08-21 | 浙江大学 | 一种基于超临界流体技术的载药伤口敷料制备方法 |
CN103315980A (zh) * | 2013-06-09 | 2013-09-25 | 浙江大学 | 一种基于超临界流体技术的黏膜附着性聚合物载药贴膜制备方法 |
CN104031386A (zh) * | 2014-05-26 | 2014-09-10 | 中国科学院宁波材料技术与工程研究所 | 一种复合气凝胶及其制备方法 |
CN104958252A (zh) * | 2015-06-24 | 2015-10-07 | 青岛农业大学 | 一种壳聚糖载药温敏水凝胶、制备方法及其应用 |
Cited By (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107855080A (zh) * | 2017-10-30 | 2018-03-30 | 中国科学院过程工程研究所 | 高分子凝胶颗粒、其制备方法、包含其的复合凝胶颗粒及用途 |
CN107855080B (zh) * | 2017-10-30 | 2020-09-08 | 中国科学院过程工程研究所 | 高分子凝胶颗粒、其制备方法、包含其的复合凝胶颗粒及用途 |
CN109985581A (zh) * | 2018-01-03 | 2019-07-09 | 天津城建大学 | 碳纳米管-蒙脱土复合气凝胶材料及其制备方法 |
CN108421081A (zh) * | 2018-04-03 | 2018-08-21 | 广东海洋大学 | 一种抗感染、安全高效的止血气凝胶及其制备方法 |
CN108421081B (zh) * | 2018-04-03 | 2019-02-05 | 广东海洋大学 | 一种抗感染、安全高效的止血气凝胶及其制备方法 |
CN108955096A (zh) * | 2018-05-22 | 2018-12-07 | 航天特种材料及工艺技术研究所 | 一种超临界二氧化碳干燥的方法 |
CN108955096B (zh) * | 2018-05-22 | 2020-04-17 | 航天特种材料及工艺技术研究所 | 一种超临界二氧化碳干燥的方法 |
CN108905884A (zh) * | 2018-06-01 | 2018-11-30 | 东南大学 | 一种改进的超临界抗溶剂法制备聚合物载药颗粒装置 |
CN112220962A (zh) * | 2020-10-30 | 2021-01-15 | 北京福爱乐科技发展有限公司 | 一种快速止血的医用胶材料及其制备方法 |
CN112263707A (zh) * | 2020-10-30 | 2021-01-26 | 北京福爱乐科技发展有限公司 | 一种抗感染医用胶材料及其制备方法 |
CN112295013A (zh) * | 2020-10-30 | 2021-02-02 | 北京福爱乐科技发展有限公司 | 一种消炎型快速止血医用胶材料及其制备方法 |
CN112316201A (zh) * | 2020-10-30 | 2021-02-05 | 北京福爱乐科技发展有限公司 | 一种抗菌型快速止血医用胶材料及其制备方法 |
CN112263707B (zh) * | 2020-10-30 | 2022-05-27 | 卫纳塞德(北京)医疗科技有限公司 | 一种抗感染医用胶材料及其制备方法 |
CN112316201B (zh) * | 2020-10-30 | 2022-06-21 | 北京福爱乐科技发展有限公司 | 一种抗菌型快速止血医用胶材料及其制备方法 |
CN112295013B (zh) * | 2020-10-30 | 2022-06-21 | 北京福爱乐科技发展有限公司 | 一种消炎型快速止血医用胶材料及其制备方法 |
CN114533965A (zh) * | 2022-02-22 | 2022-05-27 | 大连大学 | 一种聚合物基羟基磷灰石复合材料负载头孢羟氨苄及其制备方法与应用 |
CN115531615A (zh) * | 2022-09-19 | 2022-12-30 | 沈阳百奥医疗器械有限公司 | 一种浸渍载药方法 |
Also Published As
Publication number | Publication date |
---|---|
CN106110384B (zh) | 2019-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106110384A (zh) | 一种基于超临界流体技术的载药气凝胶制备方法 | |
Ruan et al. | Progress in the application of sustained-release drug microspheres in tissue engineering | |
Gao et al. | Recent advances in microfluidic-aided chitosan-based multifunctional materials for biomedical applications | |
WO2017084160A1 (zh) | 一种固体制剂制造设备和方法 | |
CN103239419B (zh) | 茶碱缓释片的制备方法 | |
CN102086234B (zh) | 一种提高中分子量羟乙基淀粉质量的制备方法 | |
CN102000034B (zh) | 一种供注射用的s-泮托拉唑钠组合物及其制备方法 | |
CN104586795B (zh) | 一种卡格列净片及其制备方法 | |
He et al. | Application of poly (N-isopropylacrylamide) as thermosensitive smart materials | |
CN107320716A (zh) | 碱性成纤维细胞生长因子囊泡及其制备方法 | |
CN107324308A (zh) | 一种核壳结构的介孔碳纳米粒及用作紫杉醇载体的用途 | |
CN103565760A (zh) | 一种福沙匹坦二甲葡胺冻干粉及制备方法 | |
Chen et al. | Hypoxic microenvironment reconstruction with synergistic biofunctional ions promotes diabetic wound healing | |
CN108042495B (zh) | 一种格列吡嗪脂质纳米粒固体制剂 | |
CN113995714B (zh) | 一种顺铂交联的蛋白水凝胶及制备方法 | |
CN106692081B (zh) | 一种泮托拉唑钠冻干粉针剂及制备方法 | |
CN107789320B (zh) | 一种氟维司群缓释注射液及其制备工艺 | |
CN103315980B (zh) | 一种基于超临界流体技术的黏膜附着性聚合物载药贴膜制备方法 | |
CN101579394B (zh) | 瓜蒌皮滴丸及其制备方法 | |
CN1981785A (zh) | 一种抗肿瘤的中药制剂 | |
CN108420807B (zh) | 一种盐酸二甲双胍药物组合物制剂及其制备方法 | |
CN1449748A (zh) | 干粉末肺部吸入用药物微球制剂及其制备方法 | |
CN111714540A (zh) | 一种挥发油类物质微纳米药物递送系统及其制备方法与应用 | |
CN105148320A (zh) | 一种载药羟基磷灰石多孔微球的制备方法及其应用 | |
CN105213323A (zh) | 一种注射用长春西汀冻干粉的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20161116 Assignee: Yixiaode (Dalian) Elderly Care Industry Service Co.,Ltd. Assignor: DALIAN University Contract record no.: X2023210000236 Denomination of invention: Preparation of drug loaded aerogel based on supercritical fluid technology Granted publication date: 20190201 License type: Common License Record date: 20231129 Application publication date: 20161116 Assignee: Qingyun (Dalian) Medical Equipment Co.,Ltd. Assignor: DALIAN University Contract record no.: X2023210000225 Denomination of invention: Preparation of drug loaded aerogel based on supercritical fluid technology Granted publication date: 20190201 License type: Common License Record date: 20231129 |
|
OL01 | Intention to license declared | ||
OL01 | Intention to license declared |